The DOI matches its Crossref record; 105 of the 105 references it cites were found in a registry or an index.
Confronting the scientific obstacles to global control of tuberculosis
Open accessAbstract
Tuberculosis (TB) is a major threat to global health, recently exacerbated by the emergence of highly drug-resistant forms of the disease-causing pathogen and synergy with HIV/AIDS.In 2006, the Stop TB Partnership published "The global plan to stop TB: 2006-2015," which set out a vision of halving the prevalence of and mortality caused by the disease by 2015, followed by eliminating the disease as a public health problem by 2050.This vision depends on the development of improved diagnostics, simpler treatment, and more effective vaccination.Recently, active translational research pipelines directed toward each of these goals have been established, but improved understanding of the fundamental biology of this complex disease will prove to be the key to radical advances in TB control.Nonstandard abbreviations used: AFB, acid-fast bacilli; BCG, bacillus Calmette-Guérin; DOTS, directly observed therapy, short course; DST, drug susceptibility testing; MDR-TB, multidrug-resistant TB; TB, tuberculosis; XDR-TB, extensively drug-resistant TB.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence
Cole, S. T., Brosch, R., Parkhill, J., Garnier, T., Churcher, C., Harris, D., Gordon, S. V., Eiglmeier, K., Gas, S., Barry, C. E., et al. (1998) · Nature · doi:10.1038/31159 · Cited by 7,847
Self-citationComplete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen
Stover, C. K., Pham, X. Q., Erwin, A. L., Mizoguchi, S. D., Warrener, P., Hickey, M. J., Brinkman, F. S. L., Hufnagle, W. O., Kowalik, D. J., Lagrou, M., et al. (2000) · Nature · doi:10.1038/35023079 · Cited by 4,573
Gralton, B. (2008) · Art monthly Australia · Cited by 3,001
The Growing Burden of Tuberculosis: Global Trends and Interactions With the HIV Epidemic
Corbett, E. L., Watt, C. J., Walker, N., Maher, D., Williams, B. G., Raviglione, M. C., & Dye, C. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.9.1009 · Cited by 2,553
Genes required for mycobacterial growth defined by high density mutagenesis
Sassetti, C. M., Boyd, D. H., & Rubin, E. J. (2003) · Molecular Microbiology · doi:10.1046/j.1365-2958.2003.03425.x · Cited by 2,544
Drugs for bad bugs: confronting the challenges of antibacterial discovery
Payne, D. J., Gwynn, M. N., Holmes, D. J., & Pompliano, D. L. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2201 · Cited by 2,512
An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection.
Flynn, J. L., Chan, J., Triebold, K. J., Dalton, D. K., Stewart, T. A., & Bloom, B. R. (1993) · The Journal of experimental medicine · doi:10.1084/jem.178.6.2249 · Cited by 2,465
A Diarylquinoline Drug Active on the ATP Synthase of Mycobacterium tuberculosis
Andries, K., Verhasselt, P., Guillemont, J., Göhlmann, H. W. H., Neefs, J.-M., Winkler, H., Van Gestel, J., Timmerman, P., Zhu, M., Lee, E., et al. (2005) · Science · doi:10.1126/science.1106753 · Cited by 2,191
Flynn, J. L., & Chan, J. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.93 · Cited by 2,155
Gandhi, N. R., Moll, A., Sturm, A. W., Pawinski, R., Govender, T., Lalloo, U., Zeller, K., Andrews, J., & Friedland, G. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69573-1 · Cited by 1,732
Selwyn, P. A., Hartel, D., Lewis, V. A., Schoenbaum, E. E., Vermund, S. H., Klein, R. S., Walker, A. T., & Friedland, G. H. (1989) · New England Journal of Medicine · doi:10.1056/nejm198903023200901 · Cited by 1,574
Khader, S. A., Bell, G. K., Pearl, J. E., Fountain, J. J., Rangel-Moreno, J., Cilley, G. E., Shen, F., Eaton, S. M., Gaffen, S. L., Swain, S. L., et al. (2007) · Nature Immunology · doi:10.1038/ni1449 · Cited by 1,439
Genetic requirements for mycobacterial survival during infection
Sassetti, C. M., & Rubin, E. J. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2134250100 · Cited by 1,354
A small-molecule nitroimidazopyran drug candidate for the treatment of tuberculosis
Stover, C. K., Warrener, P., VanDevanter, D. R., Sherman, D. R., Arain, T. M., Langhorne, M. H., Anderson, S. W., Towell, J. A., Yuan, Y., McMurray, D. N., et al. (2000) · Nature · doi:10.1038/35016103 · Cited by 1,034
Self-citationGenetic Dissection of Immunity to Mycobacteria: The Human Model
Casanova, J.-L., & Abel, L. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.081501.125851 · Cited by 991
Menzies, D., Pai, M., & Comstock, G. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-146-5-200703060-00006 · Cited by 984
M. tuberculosis and M. leprae Translocate from the Phagolysosome to the Cytosol in Myeloid Cells
van der Wel, N., Hava, D., Houben, D., Fluitsma, D., van Zon, M., Pierson, J., Brenner, M., & Peters, P. J. (2007) · Cell · doi:10.1016/j.cell.2007.05.059 · Cited by 960
Structure, function, and biogenesis of the cell wall of Mycobacterium tuberculosis
Brennan, P. J. (2003) · Tuberculosis · doi:10.1016/s1472-9792(02)00089-6 · Cited by 884
Colditz, G. A., Berkey, C. S., Mosteller, F., Brewer, T. F., Wilson, M. E., Burdick, E., & Fineberg, H. V. (1995) · Pediatrics · doi:10.1542/peds.96.1.29 · Cited by 763
A glycolipid of hypervirulent tuberculosis strains that inhibits the innate immune response
Reed, M. B., Domenech, P., Manca, C., Su, H., Barczak, A. K., Kreiswirth, B. N., Kaplan, G., & Barry, C. E. (2004) · Nature · doi:10.1038/nature02837 · Cited by 762
Self-citationTransmission of Mycobacterium tuberculosis from patients smear-negative for acid-fast bacilli
Behr, M., Warren, S., Salamon, H., Hopewell, P., de Leon, A. P., Daley, C., & Small, P. (1999) · The Lancet · doi:10.1016/s0140-6736(98)03406-0 · Cited by 754
Matsumoto, M., Hashizume, H., Tomishige, T., Kawasaki, M., Tsubouchi, H., Sasaki, H., Shimokawa, Y., & Komatsu, M. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030466 · Cited by 751
Regulation of the Mycobacterium tuberculosis hypoxic response gene encoding α-crystallin
Sherman, D. R., Voskuil, M., Schnappinger, D., Liao, R., Harrell, M. I., & Schoolnik, G. K. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.121172498 · Cited by 729
Gagneux, S., & Small, P. M. (2007) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(07)70108-1 · Cited by 712
Tuberculous Granulomas Are Hypoxic in Guinea Pigs, Rabbits, and Nonhuman Primates
Via, L. E., Lin, P. L., Ray, S. M., Carrillo, J., Allen, S. S., Eum, S. Y., Taylor, K., Klein, E., Manjunatha, U., Gonzales, J., et al. (2008) · Infection and Immunity · doi:10.1128/iai.01515-07 · Cited by 664
Self-citationComprehensive identification of conditionally essential genes in mycobacteria
Sassetti, C. M., Boyd, D. H., & Rubin, E. J. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.231275498 · Cited by 616
Ewer, K., Deeks, J., Alvarez, L., Bryant, G., Waller, S., Andersen, P., Monk, P., & Lalvani, A. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12950-9 · Cited by 615
High-throughput screening assays for the identification of chemical probes
Inglese, J., Johnson, R. L., Simeonov, A., Xia, M., Zheng, W., Austin, C. P., & Auld, D. S. (2007) · Nature Chemical Biology · doi:10.1038/nchembio.2007.17 · Cited by 614
Exogenous Reinfection as a Cause of Recurrent Tuberculosis after Curative Treatment
van Rie, A., Warren, R., Richardson, M., Victor, T. C., Gie, R. P., Enarson, D. A., Beyers, N., & van Helden, P. D. (1999) · New England Journal of Medicine · doi:10.1056/nejm199910143411602 · Cited by 610
McShane, H., Pathan, A. A., Sander, C. R., Keating, S. M., Gilbert, S. C., Huygen, K., Fletcher, H. A., & Hill, A. V. S. (2004) · Nature Medicine · doi:10.1038/nm1128 · Cited by 570
Grode, L. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24617 · Cited by 557
Exploring biology with small organic molecules
Stockwell, B. R. (2004) · Nature · doi:10.1038/nature03196 · Cited by 470
Martineau, A. R., Wilkinson, K. A., Newton, S. M., Floto, R. A., Norman, A. W., Skolimowska, K., Davidson, R. N., Sørensen, O. E., Kampmann, B., Griffiths, C. J., et al. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.11.7190 · Cited by 410
Raviglione, M. C., & Uplekar, M. W. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68392-x · Cited by 398
Barnard, M., Albert, H., Coetzee, G., O'Brien, R., & Bosman, M. E. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200709-1436oc · Cited by 391
The White Plague: Tuberculosis, Man and Society
(1954) · Medical Journal of Australia · doi:10.5694/j.1326-5377.1954.tb85837.x · Cited by 388
Contacts of cases of active pulmonary tuberculosis.
Grzybowski, S., Gd, B., & Styblo, K. (1975) · PubMed · Cited by 375
Diagnosing Tuberculosis Infection in the 21st Century
Lalvani, A. (2007) · Chest · doi:10.1378/chest.06-2471 · Cited by 350
Mycobacterium tuberculosis Growth at theCavity Surface: a Microenvironment with FailedImmunity
Kaplan, G., Post, F. A., Moreira, A. L., Wainwright, H., Kreiswirth, B. N., Tanverdi, M., Mathema, B., Ramaswamy, S. V., Walther, G., Steyn, L. M., et al. (2003) · Infection and Immunity · doi:10.1128/iai.71.12.7099-7108.2003 · Cited by 350
Self-citationBoehme, C. C., Nabeta, P., Henostroza, G., Raqib, R., Rahim, Z., Gerhardt, M., Sanga, E., Hoelscher, M., Notomi, T., Hase, T., et al. (2007) · Journal of Clinical Microbiology · doi:10.1128/jcm.02352-06 · Cited by 341
Self-citationDoes the efficacy of BCG decline with time since vaccination?
Sterne, J. A. C., Rodrigues, L. C., & Guedes, I. N. (1998) · PubMed · Cited by 310
Facing the Crisis: Improving the Diagnosis of Tuberculosis in the HIV Era
Perkins, M. D., & Cunningham, J. (2007) · The Journal of Infectious Diseases · doi:10.1086/518656 · Cited by 300
Self-citationAdvances in tuberculosis vaccine strategies
Skeiky, Y. A. W., & Sadoff, J. C. (2006) · Nature Reviews Microbiology · doi:10.1038/nrmicro1419 · Cited by 299
The BCG Story: Lessons from the Past and Implications for the Future
Fine, P. E. M. (1989) · Clinical Infectious Diseases · doi:10.1093/clinids/11.supplement_2.s353 · Cited by 295
Metronidazole is bactericidal to dormant cells of Mycobacterium tuberculosis
Wayne, L. G., & Sramek, H. A. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.9.2054 · Cited by 295
Challenges in tuberculosis drug research and development
Ginsberg, A. M., & Spigelman, M. (2007) · Nature Medicine · doi:10.1038/nm0307-290 · Cited by 283
Bucher, H. C., Griffith, L. E., Guyatt, G. H., Sudre, P., Naef, M., Sendi, P., & Battegay, M. (1999) · Aids · doi:10.1097/00002030-199903110-00009 · Cited by 282
IL-23 and IL-17 in tuberculosis
Khader, S. A., & Cooper, A. M. (2008) · Cytokine · doi:10.1016/j.cyto.2007.11.022 · Cited by 279
(1991) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1991.03470110027006 · Cited by 272
Lessons from experimental Mycobacterium tuberculosis infections
Flynn, J. L. (2006) · Microbes and Infection · doi:10.1016/j.micinf.2005.10.033 · Cited by 270
Identification of diagnostic markers for tuberculosis by proteomic fingerprinting of serum
Agranoff, D., Fernandez-Reyes, D., Papadopoulos, M. C., Rojas, S. A., Herbster, M., Loosemore, A., Tarelli, E., Sheldon, J., Schwenk, A., Pollok, R., et al. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69342-2 · Cited by 264
Emerging Challenges in Regulatory T Cell Function and Biology
Sakaguchi, S., & Powrie, F. (2007) · Science · doi:10.1126/science.1142331 · Cited by 245
Unique Transcriptome Signature of Mycobacterium tuberculosis in Pulmonary Tuberculosis
Rachman, H., Strong, M., Ulrichs, T., Grode, L., Schuchhardt, J., Mollenkopf, H., Kosmiadi, G. A., Eisenberg, D., & Kaufmann, S. H. E. (2006) · Infection and Immunity · doi:10.1128/iai.74.2.1233-1242.2006 · Cited by 243
New tools and emerging technologies for the diagnosis of tuberculosis: Part I. Latent tuberculosis
Pai, M., Kalantri, S., & Dheda, K. (2006) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.6.3.413 · Cited by 239
Pharmacodynamics and pharmacokinetics of SQ109, a new diamine‐based antitubercular drug
Jia, L., Tomaszewski, J. E., Hanrahan, C., Coward, L., Noker, P., Gorman, G., Nikonenko, B., & Protopopova, M. (2005) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705984 · Cited by 231
McIlleron, H., Meintjes, G., Burman, W. J., & Maartens, G. (2007) · The Journal of Infectious Diseases · doi:10.1086/518655 · Cited by 226
The Global Plan to Stop TB, 2006-2015.
Raviglione, M. C. (2006) · PubMed · Cited by 213
Fortsetzung der Mittheilungen über ein Heilmittel gegen Tuberculose
Koch, R. (1891) · DMW - Deutsche Medizinische Wochenschrift · doi:10.1055/s-0029-1206198 · Cited by 207
Lee, R. E., Protopopova, M., Crooks, E., Slayden, R. A., Terrot, M., & Barry, C. E. (2003) · Journal of Combinatorial Chemistry · doi:10.1021/cc020071p · Cited by 207
Self-citationLangermans, J. A. M., Andersen, P., van Soolingen, D., Vervenne, R. A. W., Frost, P. A., van der Laan, T., van Pinxteren, L. A. H., van den Hombergh, J., Kroon, S., Peekel, I., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.201404898 · Cited by 204
Horwitz, M. A., & Harth, G. (2003) · Infection and Immunity · doi:10.1128/iai.71.4.1672-1679.2003 · Cited by 201
Hopewell, P. C. (1992) · Clinical Infectious Diseases · doi:10.1093/clind/15.3.540 · Cited by 196
RUTI: A new chance to shorten the treatment of latent tuberculosis infection
Cardona, P.-J. (2006) · Tuberculosis · doi:10.1016/j.tube.2006.01.024 · Cited by 190
Palomino, J. C. (2005) · European Respiratory Journal · doi:10.1183/09031936.05.00050305 · Cited by 187
Radošević, K., Wieland, C. W., Rodriguez, A., Weverling, G. J., Mintardjo, R., Gillissen, G., Vogels, R., Skeiky, Y. A. W., Hone, D. M., Sadoff, J. C., et al. (2007) · Infection and Immunity · doi:10.1128/iai.00004-07 · Cited by 177
Brandt, L., Skeiky, Y. A. W., Alderson, M. R., Lobet, Y., Dalemans, W., Turner, O. C., Basaraba, R. J., Izzo, A. A., Lasco, T. M., Chapman, P. L., et al. (2004) · Infection and Immunity · doi:10.1128/iai.72.11.6622-6632.2004 · Cited by 174
Immune responses to tuberculosis in developing countries: implications for new vaccines
Rook, G. A. W., Dheda, K., & Zumla, A. (2005) · Nature Reviews Immunology · doi:10.1038/nri1666 · Cited by 171
Protein secretion systems in Mycobacteria
Champion, P. A. D., & Cox, J. S. (2007) · Cellular Microbiology · doi:10.1111/j.1462-5822.2007.00943.x · Cited by 167
From the Centers for Disease Control
Morris, J. G., West, G. R., Holck, S. E., Blake, P. A., Echeverria, P. D., & Karaulnik, M. (1982) · Journal of Infectious Diseases · doi:10.1093/infdis/145.1.131 · Cited by 165
Boehme, C., Molokova, E., Minja, F., Geis, S., Loscher, T., Maboko, L., Koulchin, V., & Hoelscher, M. (2005) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/j.trstmh.2005.04.014 · Cited by 163
Optimizing sputum smear microscopy for the diagnosis of pulmonary tuberculosis
Steingart, K. R., Ramsay, A., & Pai, M. (2007) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.5.3.327 · Cited by 159
Moxifloxacin (BAY12-8039), a New 8-Methoxyquinolone, Is Active in a Mouse Model of Tuberculosis
Miyazaki, E., Miyazaki, M., Chen, J. M., et al. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.1.85 · Cited by 145
Musser, J. M., Amin, A. G., & Ramaswamy, S. V. (2000) · Genetics · doi:10.1093/genetics/155.1.7 · Cited by 143
Rapid diagnosis of tuberculosis by detection of mycobacterial lipoarabinomannan in urine
Hamasur, B., Bruchfeld, J., Haile, M., Pawlowski, A., Bjorvatn, B., Källenius, G., & Svenson, S. B. (2001) · Journal of Microbiological Methods · doi:10.1016/s0167-7012(01)00239-1 · Cited by 140
Impact of the HIV epidemic on the spread of other diseases: the case of tuberculosis.
Girardi, E., Raviglione, M. C., Antonucci, G., Godfrey‐Faussett, P., & Ippolito, G. (2000) · PubMed · Cited by 139
Foundation for Innovative New Diagnostics
(2009) · Springer eBooks · doi:10.1007/978-0-387-78665-0_5669 · Cited by 136
Protective immunity to tuberculosis with Ag85B-ESAT-6 in a synthetic cationic adjuvant system IC31
Agger, E. M., Rosenkrands, I., Olsen, A. W., Hatch, G. J., Williams, A., Kritsch, C. E., Lingnau, K., von Gabain, A., Andersen, C. S., Korsholm, K. S., et al. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.03.072 · Cited by 128
Prospects for Clinical Introduction of Nitroimidazole Antibiotics for the Treatment of Tuberculosis
Barry, C. E., Boshoff, H. I., & Dowd, C. S. (2004) · Current Pharmaceutical Design · doi:10.2174/1381612043383214 · Cited by 128
Self-citationMatteelli, A., Migliori, G. B., Cirillo, D. M., Centis, R., Girardi, E., & Raviglione, M. C. (2007) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.5.5.857 · Cited by 124
Smith, D. W., McMurray, D. N., Wiegeshaus, E. H., Grover, A. A., & Harding, G. E. (1970) · PubMed · doi:10.1164/arrd.1970.102.6.937 · Cited by 111
Th1 memory: implications for vaccine development
Foulds, K. E., Wu, C. Y., & Seder, R. A. (2006) · Immunological Reviews · doi:10.1111/j.0105-2896.2006.00400.x · Cited by 110
CD1-Restricted T Cells in Host Defense to Infectious Diseases
Behar, S. M., & Porcelli, S. A. (2007) · Springer eBooks · doi:10.1007/978-3-540-69511-0_9 · Cited by 106
In vivo veritas: The search for TB drug targets goes live
McKinney, J. D. (2000) · Nature Medicine · doi:10.1038/82142 · Cited by 96
Short-course therapy of acute cystitis: a brief review of therapeutic strategies
Tice, A. D. (1999) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/43.suppl_1.85 · Cited by 93
Paramasivan, C. N., Sulochana, S., Kubendiran, G., Venkatesan, P., & Mitchison, D. A. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.2.627-631.2005 · Cited by 91
New diagnostic tools for tuberculosis.
Perkins, M. D. (2000) · PubMed · Cited by 89
Self-citation“The White Plague, Tuberculosis, Man and Society,”
René (1953) · Diseases of the Chest · doi:10.1016/s0096-0217(16)32336-6 · Cited by 89
Hasegawa, N., Miura, T., Ishii, K., Yamaguchi, K., Lindner, T. H., Merritt, S., Matthews, J. D., & Siddiqi, S. H. (2002) · Journal of Clinical Microbiology · doi:10.1128/jcm.40.3.908-912.2002 · Cited by 88
Chemical ligands, genomics and drug discovery
Lenz, G. R., Nash, H. M., & Jindal, S. (2000) · Drug Discovery Today · doi:10.1016/s1359-6446(00)01468-9 · Cited by 84
Gupta, U. D., Katoch, V. M., & McMurray, D. N. (2007) · Vaccine · doi:10.1016/j.vaccine.2007.01.112 · Cited by 81
Proteins unique to intraphagosomally grown Mycobacterium tuberculosis
Mattow, J., Siejak, F., Hagens, K., Becher, D., Albrecht, D., Krah, A., Schmidt, F., Jungblut, P. R., Kaufmann, S. H. E., & Schaible, U. E. (2006) · PROTEOMICS · doi:10.1002/pmic.200500547 · Cited by 78
The DOTS Strategy for Controlling the Global Tuberculosis Epidemic
Frieden, T. R., & Munsiff, S. S. (2005) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2005.02.001 · Cited by 78
Smukste, I., & Stockwell, B. R. (2005) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev.genom.6.080604.162136 · Cited by 77
Diagnostic Evaluation of Urinary Lipoarabinomannan at an Ethiopian Tuberculosis Centre
Tsigeweini Asgedom Tessema, B. (2001) · Scandinavian Journal of Infectious Diseases · doi:10.1080/003655401300077306 · Cited by 77
Use of the bovine model of tuberculosis for the development of improved vaccines and diagnostics
Hewinson, R. G., Vordermeier, H. M., & Buddle, B. M. (2003) · Tuberculosis · doi:10.1016/s1472-9792(02)00062-8 · Cited by 75
Pathan, A. A., Sander, C. R., Fletcher, H. A., Poulton, I. D., Alder, N. C., Beveridge, N. E. R., Whelan, K. T., Hill, A. V. S., & McShane, H. (2007) · PLoS ONE · doi:10.1371/journal.pone.0001052 · Cited by 71
Anthony, R. M., Kolk, A. H. J., Kuijper, S., & Klatser, P. R. (2006) · PubMed · Cited by 64
Identification and Validation of Novel Drug Targets in Tuberculosis
Duncan, K. (2004) · Current Pharmaceutical Design · doi:10.2174/1381612043383223 · Cited by 60
Self-citationPotential of Mw as a prophylactic vaccine against pulmonary tuberculosis
Katoch, K., Singh, P., Adhikari, T., Benara, S. K., Singh, H., Chauhan, D. S., Sharma, V. D., Lavania, M., Sachan, A. S., & Katoch, V. M. (2008) · Vaccine · doi:10.1016/j.vaccine.2007.12.025 · Cited by 53
QuantiFERON-TB Gold: state of the art for the diagnosis of tuberculosis infection?
Connell, T. G., Rangaka, M. X., Curtis, N. C., & Wilkinson, R. J. (2006) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.6.5.663 · Cited by 53
Bjune, G. A., Hamasur, B., Tessema, T. A., Svenson, S. B., Syre, H., & Bjorvatn, B. (2002) · Scandinavian Journal of Infectious Diseases · doi:10.1080/00365540110077263 · Cited by 44
Tessema, T. A., Bjune, G. A., Assefa, G., Svenson, S. B., Hamasur, B., & Bjorvatn, B. (2002) · Scandinavian Journal of Infectious Diseases · doi:10.1080/00365540110077254 · Cited by 35
Sander, C. R., & McShane, H. (2007) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2006.03306.x · Cited by 33
New genetic approaches shed light on TB virulence
Murry, J. P., & Rubin, E. J. (2005) · Trends in Microbiology · doi:10.1016/j.tim.2005.06.003 · Cited by 15
Management and outcome of TB suspects admitted to the medical wards of a central hospital in Malawi
Friend, J. H., Mason, S., Harries, A. D., Salaniponi, F. M. L., & Neuhann, F. (2005) · Tropical Doctor · doi:10.1258/0049475054037165 · Cited by 6
Cited by
An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis
Berry, M. P. R., Graham, C. M., McNab, F. W., Xu, Z., Bloch, S. A. A., Oni, T., Wilkinson, K. A., Banchereau, R., Skinner, J., Wilkinson, R. J., et al. (2010) · Nature · doi:10.1038/nature09247 · Cited by 1,898
The Immune Response in Tuberculosis
O'Garra, A., Redford, P. S., McNab, F. W., Bloom, C. I., Wilkinson, R. J., & Berry, M. P. R. (2013) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032712-095939 · Cited by 1,342
Cell-Mediated Immune Responses in Tuberculosis
Cooper, A. M. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132703 · Cited by 1,162
The Diarylquinoline TMC207 for Multidrug-Resistant Tuberculosis
Diacon, A. H., Pym, A., Grobusch, M., Patientia, R., Rustomjee, R., Page-Shipp, L., Pistorius, C., Krause, R., Bogoshi, M., Churchyard, G., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808427 · Cited by 835
Benzothiazinones Kill Mycobacterium tuberculosis by Blocking Arabinan Synthesis
Makarov, V., Manina, G., Mikusova, K., Möllmann, U., Ryabova, O., Saint-Joanis, B., Dhar, N., Pasca, M. R., Buroni, S., Lucarelli, A. P., et al. (2009) · Science · doi:10.1126/science.1171583 · Cited by 740
Metadata
- Authors
- Young, D. B., Perkins, M. D., Duncan, K., & Barry, C. E.
- Venue
- Journal of Clinical Investigation
- Published
- 2008-04-01
- Volume
- 118
- Issue
- 4
- Pages
- 1255-1265
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2073502830
- Cited by
- 324
- References
- 105
- FWCI
- 23.47
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.